Status:
COMPLETED
Male Hormonal Contraceptive Development-ACY-5
Lead Sponsor:
University of Washington
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CONRAD
Conditions:
Contraception
Eligibility:
MALE
18-55 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this research study is to help in the development of male contraception (birth control).
Detailed Description
The objective is to conduct a male contraceptive trial in which we will evaluate the suppressive effects of acyline when administered in combination with Testosterone (T) and the progestin depo-medrox...
Eligibility Criteria
Inclusion
- Males between 18-55
- In good general health
- With normal sperm counts
- Willing to use an acceptable form of contraception
Exclusion
- Men in poor health
- Significant chronic or acute medical illness
- Skin conditions that might interfere with or be exacerbated by testosterone gel
- Known history of alcohol, illicit drug or anabolic steroid abuse
- Abnormal reproductive function
- Participation in a long-term male contraceptive study within past three months
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2006
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT00161447
Start Date
May 1 2004
End Date
April 1 2006
Last Update
September 19 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington
Seattle, Washington, United States, 98195